Zobrazeno 1 - 10
of 675
pro vyhledávání: '"G Tancini"'
Autor:
Kohsaka, Yasuhiro1,2 (AUTHOR) kohsaka@shinshu-u.ac.jp, Matsuura, Daisuke3 (AUTHOR), Kimura, Yoshikazu3 (AUTHOR) kimura.yoshikazu@iharanikkei.co.jp
Publikováno v:
Communications Chemistry. 11/13/2024, Vol. 7 Issue 1, p1-10. 10p.
Publikováno v:
Journal of Pineal Research. 35:12-15
Numerous experimental data have documented the oncostatic properties of melatonin. In addition to its potential direct antitumor activity, melatonin has proved to modulate the effects of cancer chemotherapy, by enhancing its therapeutic efficacy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ed43a663b0bd7938013925848838f8c
https://doi.org/10.1034/j.1600-079x.2003.00032.x
https://doi.org/10.1034/j.1600-079x.2003.00032.x
Autor:
F. Paolorossi, Sandro Barni, M. Chilelli, G Tancini, Antonio Ardizzoia, Ario Conti, M. Mancuso, Georges J.M. Maestroni, Paolo Lissoni
Publikováno v:
Journal of Pineal Research. 23:15-19
Recent studies suggest that the pineal hormone melatonin may reduce chemotherapy-induced immune and bone marrow damage. In addition, melatonin may exert potential oncostatic effects either by stimulating host anticancer immune defenses or by inhibiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aebe17a438cf1c29cc9faef4a7a281e
https://doi.org/10.1111/j.1600-079x.1997.tb00329.x
https://doi.org/10.1111/j.1600-079x.1997.tb00329.x
Publikováno v:
Oncology reports. 4(1)
Polychemotherapy represents the only standard medical therapy of metastatic soft tissue sarcomas (STS), whereas the recent biotherapies with cytokines, such as interleukin-2 (IL-2), seem not to have a relevant therapeutic role. The pineal hormone mel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ff073179c21bcfd6e7b74d102a42181
https://pubmed.ncbi.nlm.nih.gov/21590033
https://pubmed.ncbi.nlm.nih.gov/21590033
Autor:
Giuseppe Ricciardi, P.F. Conte, Masaharu Yoshihara, J. Limon, T. Jørgensen, B.E. Christensen, Sachio Fushida, Motofumi Yoshida, Ikuo Takahashi, Keizo Sugimachi, Koji Sumii, J. Schädelin, Claudio Rolim Teixeira, Enrico Colli, H. Hasle, D. Gardiner, Masahito Sugimura, Vittorio Gebbia, Salvatore Restivo, S. Barni, H. Birgens, M.A. Nagai, C.H. Wilder-Smith, A. Drivsholm, Yasunori Emi, Demetrios Minaretzis, M. Hrženjak, O.H.G. Wilder-Smith, Giuseppe Del Favero, Antonio Testa, M.M. Brentani, N.E. Hansen, Fabio Parazzini, Daniel Mordochovich, G. Seitz, Michael D. Melekos, L.A. Marques, G Cannata, M.M. Hansen, P. Lissoni, P.M. Suter, A. Borgeat, Yutaka Yonemura, Fumio Shimamoto, C Ferrara, M. Boogaerts, Daniela Basso, N. Blin, N.A. Peterslund, Elise Kokron, Mario Plebani, V. Jønsson, I. Kardaś, Noboru Konishi, Giovanni Spadafora, Yoshio Hiasa, Luca Tozzi, N. Žarković, Walter Paukovits, Lucia Desser, M. Forni, G.J.M. Maestroni, Tetsuya Kusumoto, S. Taesch, Francesco Mangano, Paola Fogar, M. Jurin, Bosco Lopez Saez, Z. Ilić, A. Rubagotti, Hiroto Nishioka, Roberto Valenza, J. Nikoskelainen, A. Ardizzoia, Marco Scatigna, Shinji Tanaka, Giuseppe Zerillo, Tamara Meggiato, Alexander Rehberger, Nicola Gebbia, Kouichiro Tsugawa, C. Welter, A. Niezabitowski, Gianfranco Cupido, A. Ferrant, Yoshiteru Kitahori, Diana Rinkevitch, Yehudith Ben-Arieh, Isao Hayashi, Federico Ingria, A. Conti, Ken Haruma, G. Gardin, Khalida P. Salim, Lael Best, Shunji Kohnoe, Shad S. Akhtar, I. Sklenar, G. Verhoef, D. Aravantinos, Goro Kajiyama, Walter Markiewicz, G. Schiffman, K.D. Christensen, Carmelo Barbaccia, R. Rosso, G. Bertelli, Angelo Burlina, G. Tancini, Stylianos Michalas, Zareefa A. Bano, G. Towse, Rebsdorf Pedersen, H. Torloni, Christina Tsionou, P. Pronzato, Antonis Keramopoulos, Yoshihiko Maehara, J. Ryś, Senra Varela, F. Rovelli, R. Lahtinen
Publikováno v:
Oncology. 50:I-VI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0a1cf8df5397552c9bdce4fb5e699d0
https://doi.org/10.1159/000227216
https://doi.org/10.1159/000227216
Autor:
G. Cattaneo, Yoshiya Katsura, Fabrizio Franchi, Takashi Yoshida, Ilona Péter, Hideaki Mizoguchi, Shuji Hashimoto, Reinhard Becher, Isao Sekiguchi, Klea Katsouyanni, Toshiteru Ohshima, Richard C. Moon, Jonathan S.T. Sham, Noriyuki Tatsumi, Herbert Höfeler, Peter Boyle, Ikuro Kimura, Ewan Cameron, S. Eckhardt, Tokujiro Yano, Sumiaki Tsuru, Diana Giannarelli, Masami Hirano, Kiyoshi Takatsuki, Arun B. Barua, Nina Konovalova, Rajendra G. Mehta, Nobuyuki Hara, B.P. Barna, Tohru Nakamura, Rudolf Richter, F. Fraschini, Patrizia Seminara, L.C. Chan, James A. Olson, Hiroshi Asoh, Nariyoshi Shinomiya, Masayuki Kawasaki, János Szántó, S.L. Loke, M.J. Thomassen, G. Esposti, Ryuzo Ohno, D. Esposti, Kuniyuki Imai, Dieter May, Jun Minowada, Masayuki Gotoh, G. Tancini, Kikuo Nomoto, Takeshi Otani, Otto Kloke, J. Sergi, Mitsuaki Suzuki, Tomoharu Kuda, Keisuke Toyama, S. Barni, Kazumasa Yamada, Yukito Ichinose, Max E. Scheulen, D. Choy, R.M. Bukowski, J. Szántó, Carl G. Schmidt, Thomas Jack, Yoshinobu Matsuo, Norbert Niederle, Kornél Daubner, Masayuki Noritake, Kiyoji Kimura, Masaaki Kosaka, Allan Campbell, P. Lissoni, S. Murthy, Taro Tamada, Dimitrios Trichopoulos, Tohru Masaoka, T. Fleischmann, Pratima Sur, Mitsuo Ohta, U. B. Wandl, Gábor Ringwald, Toshihiko Yamaya, György Liszka, Zsigmond Karika
Publikováno v:
Oncology. 48:I-VI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c667d743bb097c6ad1eee2477bff5304
https://doi.org/10.1159/000226976
https://doi.org/10.1159/000226976
Autor:
Simonetta Viviani, G. Tancini, A. Conti, Franco Rovelli, Barni S, Georges J.M. Maestroni, P. Lissoni
Publikováno v:
European Journal of Cancer and Clinical Oncology. 26:33-36
In an attempt to further understand the biological significance of soluble IL-2 receptors (sIL-2R) in solid tumors, we have evaluated 160 cancer patients (breast: 40; lung: 66; colon: 18; stomach: 22; uterine cervix: 14) and 58 healthy subjects, as c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d48bbe3bd65352c84added4c5c6466b
https://doi.org/10.1016/0277-5379(90)90253-p
https://doi.org/10.1016/0277-5379(90)90253-p
Publikováno v:
Journal of biological regulators and homeostatic agents. 17(4)
According to recent advances in psychoneuroimmunology concerning the neurobiochemistry of emotions, the pshychological status of cancer patients should be investigated in relation to the function of the psychoneurodocrine system, in an attempt to put
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cda445aff9dc4102fc59b59c313272a5
https://pubmed.ncbi.nlm.nih.gov/15065761
https://pubmed.ncbi.nlm.nih.gov/15065761
Autor:
P, Lissoni, G, Messina, M, Vaghi, E, Bartolacelli, L L, Massarenti, P, Trabattoni, P, Meregalli, M, Meregalli, C, Gavazzeni, F, Rovelli, G, Tancini, G S, Gardani
Publikováno v:
In vivo (Athens, Greece). 17(6)
In addition to the occurrence of pain, the evidence of a diminished capacity to feel pleasure is one of the most common cancer-related symptoms. Recent advances in psychoneuroendocrinological knowledge has shown that the perception of pleasure is mai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::573d00c38ebe77c781254b95ea8dfc06
https://pubmed.ncbi.nlm.nih.gov/14758733
https://pubmed.ncbi.nlm.nih.gov/14758733
Publikováno v:
Journal of pineal research. 35(1)
Numerous experimental data have documented the oncostatic properties of melatonin. In addition to its potential direct antitumor activity, melatonin has proved to modulate the effects of cancer chemotherapy, by enhancing its therapeutic efficacy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e06e7733e204f853972899ea5ddba84
https://pubmed.ncbi.nlm.nih.gov/12823608
https://pubmed.ncbi.nlm.nih.gov/12823608